Trusted Products to eXpedite Your Discovery & Development – Advance Confidently

Eurofins DiscoverX® is the trusted drug discovery and development product solutions provider. As the products division of Eurofins Discovery, and part of the Eurofins BioPharma global network, DiscoverX has earned this reputation over the past two decades by contributing to the discovery and development of life-saving therapeutics with trusted and validated cell-based assay products used in the screening and validation of billions of data points for countless therapeutic programs. The DiscoverX product portfolio is comprised of fit-for-purpose solutions, from ready-to-use homogeneous assay kits, stable engineered cell lines, membrane preps, recombinant proteins/enzymes, and qualified reagents to support your therapeutic drug programs no matter what stage you are at to accelerate your programs with confidence.

Eurofins DiscoverX develops and manufactures cell-based assays, engineered cell lines, proteins, reagents, and custom development capabilities for drug discovery and development programs from our two R&D Manufacturing Centers of Excellence: USA (San Francisco Bay Area, California) and the EU (France). Our California site focuses on product solutions based on Eurofins DiscoverX’s patented Enzyme Complementation Technology (EFC) technology to interrogate biomolecular reactions for advancing therapeutic drug screening and development programs. This technology is the basis behind our cell-based assays used for basic research and discovery through the commercial release of many small molecule drugs and biological therapeutics now on the market, with many more to come. Our France site focuses on the development and manufacturing of recombinant proteins, including high-quality active, inactive, unactive, and mutant kinases that originated as part of Upstate and became part of Merck Millipore.

Rediscover how Eurofins DiscoverX’s expertise and trusted products can help accelerate your programs and enable you to advance your drug to the next phase with confidence. Utilize end-to-end support every step of the way for your programs from discovery to QC lot release.

Eurofins DiscoverX is an ISO 9001:2015 Certified Manufacturer of Cell Based Assays and Reagents

Eurofins DiscoverX is committed to quality. Quality is not just a part of what we do but, at the core of our identity. ISO 9001:2015 certification reflects our relentless commitment to ensuring our products’ efficacy, accuracy, reproducibility, and reliability. This certification signifies our dedication to the quality of our products by meeting and exceeding internationally recognized quality standards, from R&D through manufacturing to distribution.

Eurofins DiscoverX is an ISO 9001:2015 Certified Manufacturer of Cell Based Assays and Reagents

Our Mission

Your goal is to be first to market with the best-in-class therapeutics while ensuring long-term success – that is where we come in. At Eurofins DiscoverX, we are committed to empowering and accelerating your multi-modality drug discovery and development from discovery to QC lot release. Our portfolio of high-quality products and custom solutions allows you to expedite your research and move your candidate through the drug discovery pipeline faster; erasing months to years off your timeline.

Capabilities Highlights

  • Enabling Technologies and Robust Assays – Improve productivity and effectiveness of your target validation, screening, lead optimization, and structure-activity relationships campaigns to accelerate the advancement of new therapeutics
  • Comprehensive Portfolio – Offering the largest portfolio of cell-based functional and binding assays, cell lines, and proteins/enzymes covering the top therapeutic target classes including GPCRs, kinases, checkpoint inhibitors, cytokine receptors, ion channels, and more
  • Support Every Step of the Way – End-to-end support for your programs from discovery, through development, to commercial release and stability QC lot release testing

Supporting Your Journey with Cell-Based Assays and Capabilities for Characterization, Screening, Profiling, Potency, and Lot Release Programs

The Eurofins DiscoverX portfolio of high-quality products and custom assays enables you to expedite your research and move your candidate through the drug discovery pipeline faster.

Supporting Your Journey with Cell-Based Assays and Capabilities for Characterization, Screening, Profiling, Potency, and Lot Release Programs
Programs

Global Programs using Eurofins DiscoverX Bioassays for Potency, Stability, and NAb Testing for Drug Release

Global Programs using Eurofins DiscoverX Bioassays for Potency, Stability, and NAb Testing for Drug Release

Eurofins DiscoverX bioassays are fit-for-purpose for implementation in QC lot-release for potency testing, helping to accelerate the time-to-market for therapeutics by 6 to 9 months, and ensuring high lot-to-lot reproducibility and accuracy for the life of the program. These assays can be readily transferred and implemented in potency and stability programs that typically happen under GMP conditions at the sponsors’ testing sites or partner CRO/CDMO sites. Access off-the-shelf bioassay kits that have been successfully implemented in 100+ global programs covering popular and unique druggable target classes. NA = North America, EU = Europe, APAC = Asia Pacific, and NAb = Neutralizing Antibody.